Salta al contenuto principale

Per favore
selezionare il paese

Attenzione, le pagine di questa sezione sono disponibili solo in lingua inglese.

Selezionando la visualizzazione internazionale, l'utente dichiara di risiedere al di fuori degli Stati Uniti e di voler visualizzare le informazioni sui prodotti internazionali di DiaSorin Molecular. Questo materiale è destinato esclusivamente ai visitatori internazionali (non statunitensi) del sito.

Ai sensi delle Linee Guida del Ministero della Salute del 28/03/2013 in materia di pubblicità sanitaria relativa a dispositivi medici, dispositivi medico-diagnostici in vitro e presidi medico-chirurgici, si informa che le informazioni contenute in questo sito e alle quali si accede sono destinate esclusivamente agli operatori professionali.

xTAG® Cystic Fibrosis (CFTR)

Help clinicians detect and identify the most common CFTR mutations

xTAG® CFTR is a highly scalable genetic test with clinically relevant mutations.

DNA

Disease state

Cystic fibrosis affects the cells that produce mucus, sweat, and digestive juices. It causes these fluids to become thick and sticky. They then plug up tubes, ducts, and airways in the body.

Symptoms vary and can include cough, repeated lung infections, inability to gain weight, and fatty stools. Treatments may ease symptoms and reduce complications. Newborn screening helps with early diagnosis.

Cystic fibrosis mutations are inherited and can lead to a cascade of problems

The value of xTAG® Cystic Fibrosis (CFTR)

Empower clinicians to have the ability to test for the 23 CFTR mutations recommended by ACMG/ACOG.

Flexible

Obtain the flexibility to meet your mutation coverage needs.

Simple

Simplify workflow with faster assay turnaround times.

Reliable

Utilize IVD-cleared assay with 100% overall accuracy and >91% precision (after allowable re-runs).

How the xTAG® Cystic Fibrosis (CFTR) test works

xTAG® Cystic Fibrosis (CFTR) is a multiplexed nucleic acid test intended for the detection of clinically relevant mutations by ACMG/ACOG.

01

High complexity workflow

Nucleic acid extraction and purification, multiplex amplification, bead hybridization and detection, and data acquisition and analysis by Luminex® 200™ with xPONENT® software.

02

Time to results

Within 8 hours, a laboratory can detect and determine the relevant genotypes for their clients. 

Indications for xTAG® Cystic Fibrosis (CFTR) test use

System

The xTAG® Cystic Fibrosis kits are used to simultaneously detect and identify a panel of mutations and variants in human blood specimens

xTAG® Cystic Fibrosis (CFTR) kit

The xTAG® CFTR kits are available in two different configurations for basic and expanded mutation testing.

Targeted CF Panel Tests

xTAG® CF39v2

xTAG® CF71v2

For use with Luminex® 200™ System with xPONENT®

xTAG® Cystic Fibrosis (CFTR) Test rapidly and accurately detects relevant mutations via the Luminex® 200TM system with xPONENT® Software.

Delivery of this time-critical information allows clinicians to provide targeted patient care more quickly.

xTAG® Cystic Fibrosis (CFTR) Test makes it a valuable system for use in specialized laboratories with high-complexity testing capabilities.

xTAG® Cystic Fibrosis (CFTR) v2 assays ordering info

Part Name
Kit Size
Registration Status
Part Number

xTAG® Cystic Fibrosis (CFTR) 39 Kit v2

96

CE-IVD

I027C0232

xTAG® Cystic Fibrosis (CFTR) 71 Kit v2

96

CE-IVD

I024C0185

Resources

Diasorin document repository

Dialog

Luminex document repository

Discover more

Research publications

Discover more

More details about xTAG® Cystic Fibrosis (CFTR)

Get in touch

If you need any information about our products, contact our specialists. 

Contact us

Need any help?

Get help with Diasorin products and services.

Ask for support